Coronary Artery Disease (CAD) Clinical Trials in Beijing
5 recruitingBeijing, China
Showing 1–5 of 5 trials
Recruiting
Phase 2
A Study of SRSD107 in Participants With Chronic Coronary and/or Peripheral Arterial Disease
Peripheral Arterial DiseaseCoronary Artery Disease (CAD)
Sirius Therapeutics Co., Ltd.104 enrolled1 locationNCT07318155
Recruiting
Multi-Omics-Based Novel Thrombosis and Bleeding Markers and Risk Model for CHD
ThrombosisBleedingCoronary Artery Disease (CAD)
Xueyan Zhao12,154 enrolled3 locationsNCT07523880
Recruiting
Phase 3
Comparison of Diagnostic Accuracy Between XTR004 PET MPI and the Composite Index of Quantitative Coronary Angiography (QCA) and Fractional Flow Reserve (FFR)
Coronary Artery Disease (CAD)
Sinotau Pharmaceutical Group395 enrolled5 locationsNCT07439133
Recruiting
Clinical Implications of Three-vessel Ultrasonic Flow Ratio Measurement in Patients With Coronary Artery Disease
Coronary Artery Disease (CAD)
China National Center for Cardiovascular Diseases494 enrolled1 locationNCT06822894
Recruiting
AI Facial Analysis Algorithm to Screening Coronary Artery Disease in High-Risk Community Population
ScreeningCoronary Artery Disease (CAD)Artificial Intelligence Algorithms+1 more
China National Center for Cardiovascular Diseases1,392 enrolled3 locationsNCT07277686